Cargando…

Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.

Griseofulvin(GF) has become the drug of choice as an antifungal agent for patients who suffer from many kinds of fungal infection. In order to clarify hepatic injury by griseofulvin(GF) overload and the effect of UDCA on GF-induced hepatic injury, the authors carried out biochemical, histologic, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, S. W., Han, J. H., Lim, K. T., Cho, H. M., Chung, K. W., Sun, H. S., Park, D. H., Kim, B. S., Seo, E. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Academy of Medical Sciences 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049691/ https://www.ncbi.nlm.nih.gov/pubmed/1751019

Ejemplares similares

Experimental Protoporphyria: Effect of Bile Acids on Liver Damage Induced by Griseofulvin
por: Martinez, María del Carmen, et al.
Publicado: (2015)

Protective Action of Antioxidants on Hepatic Damage Induced by Griseofulvin
por: Martinez, M. del C., et al.
Publicado: (2014)

Acute Hepatic Porphyria
por: Bissell, D. Montgomery, et al.
Publicado: (2015)

PORPHYRIA—A ROYAL MALADY
por: McMenemey, W. H.
Publicado: (1969)

Griseofulvin: An Updated Overview of Old and Current Knowledge
por: Aris, Parisa, et al.
Publicado: (2022)

Treatment of Generalized Granuloma Annulare with Oral Griseofulvin
por: Chumsaengsri, Chumsaeng, et al.
Publicado: (2022)

Preparation and Optimization OF Palm-Based Lipid Nanoparticles Loaded with Griseofulvin
por: Huei Lim, Wen, et al.
Publicado: (2017)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

Infectious Mononucleosis and Porphyria
por: Dawson, T. A. J., et al.
Publicado: (1962)

Preparation and Microstructural Characterization of Griseofulvin Microemulsions Using Different Experimental Methods: SAXS and DSC
por: Moghimipour, Eskandar, et al.
Publicado: (2017)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Spatial and Temporal Profiling of Griseofulvin Production in Xylaria cubensis Using Mass Spectrometry Mapping
por: Sica, Vincent P., et al.
Publicado: (2016)

Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice
por: Yang, Jae-Seong, et al.
Publicado: (2010)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Acute hepatic porphyria and hepatocellular carcinoma.
por: Kauppinen, R., et al.
Publicado: (1988)

Endothelial Dysfunction in Acute Hepatic Porphyrias
por: Ricci, Andrea, et al.
Publicado: (2022)

Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi‐centre, randomised, double‐blinded, placebo‐controlled trial
por: Oh, B., et al.
Publicado: (2016)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

Draft Genome Sequence of the Griseofulvin-Producing Fungus Xylaria flabelliformis Strain G536
por: Mead, Matthew E., et al.
Publicado: (2019)

Effect of Hydrophilic Diluents on the Release Profile of Griseofulvin from Tablet Formulations
por: Umeh, O. N. C., et al.
Publicado: (2013)

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
por: Caballero‐Camino, Francisco J., et al.
Publicado: (2020)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Thyroid tumours in rats and hepatomas in mice after griseofulvin treatment.
por: Rustia, M., et al.
Publicado: (1978)

Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Maiolo, Corinne, et al.
Publicado: (2016)

Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats
por: Khoza, Star, et al.
Publicado: (2017)

The Effects of Ursodeoxycholic Acid Pretreatment in an Experimental Setting of Extended Hepatectomy: A Feasibility Study
por: Paspala, Anna, et al.
Publicado: (2020)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Design, Synthesis, and Cytotoxicity Evaluation of Novel Griseofulvin Analogues with Improved Water Solubility
por: Hamdy, Ahmed K., et al.
Publicado: (2017)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
por: John, Jason J., et al.
Publicado: (2021)

Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study
por: Smith, Clare M., et al.
Publicado: (2017)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

Acute Porphyria
por: Kernohan, R. J., et al.
Publicado: (1954)

Pain in acute hepatic porphyrias: Updates on pathophysiology and management
por: Kazamel, Mohamed, et al.
Publicado: (2022)

The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model
por: Ainosah, Randa H., et al.
Publicado: (2020)

Acute Hepatic Porphyrias: Review and Recent Progress
por: Wang, Bruce, et al.
Publicado: (2018)

Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias
por: Ricci, Andrea, et al.
Publicado: (2021)

Pathogenesis of acute encephalopathy in acute hepatic porphyria
por: Pischik, Elena, et al.
Publicado: (2023)

THE PORPHYRIAS
Publicado: (1981)

Hepatitis C- and HIV-induced porphyria cutanea tarda
por: Quansah, Raphael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t3mdkgd7fpsr6sbak120untjnv